• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单中心回顾性人工智能训练队列研究早期 TIPS 治疗后肝性脑病、死亡率和肝功能障碍的预后预测。

Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation.

机构信息

Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, No. 188, Shizi Street, Suzhou, 215006, China.

出版信息

Cardiovasc Intervent Radiol. 2021 Oct;44(10):1597-1608. doi: 10.1007/s00270-021-02907-0. Epub 2021 Jul 8.

DOI:10.1007/s00270-021-02907-0
PMID:34240232
Abstract

OBJECTIVES

Based on an artificial intelligence approach, this study attempted to establish prognostic models to predict 3-month overt hepatic encephalopathy (OHE) occurrence, 1-year mortality, and liver dysfunction for cirrhotic patients with acute variceal bleeding (AVB) treated with early transjugular intrahepatic portosystemic shunt (TIPS) creation.

MATERIALS AND METHODS

This retrospective study included patients treated with early TIPS between January 2016 and November 2019. Independent risk factors associated with occurrence of OHE within 3 months, 1-year mortality, and liver dysfunction after early TIPS were identified using univariate and multivariate logistic analyses. Artificial neural network (ANN) models and prognostic nomograms based on the independent risk factors were established and validated internally.

RESULTS

A total of 207 patients were included, with 33 (15.9%) experienced OHE within 3 months after TIPS creation. The albumin-bilirubin grade (P = 0.015), age (≤ 65, > 65 years) (P < 0.001), gender (P = 0.002), and alcoholic cirrhosis (P = 0.013) was identified as independent risk factors associated with 3-month OHE. Presence of portal vein thrombosis (P = 0.034) and model for end-stage liver disease score (P = 0.063) were identified as independent risk factors associated with 1-year mortality. The platelet-albumin-bilirubin grade (P = 0.041) and a history of hepatic encephalopathy (P = 0.018) were identified as independent risk factors associated with liver dysfunction after TIPS creation. Three ANN models and three nomograms were then established and validated with high accuracy.

CONCLUSIONS

The ANN and nomogram models have potential to accurately predict early occurrence of OHE, mortality, and liver dysfunction after early TIPS creation for cirrhotic patients with AVB.

摘要

目的

基于人工智能方法,本研究试图建立预测模型,以预测接受早期经颈静脉肝内门体分流术(TIPS)治疗的肝硬化急性静脉曲张出血(AVB)患者发生 3 个月显性肝性脑病(OHE)、1 年死亡率和肝功能障碍的风险。

材料和方法

本回顾性研究纳入了 2016 年 1 月至 2019 年 11 月期间接受早期 TIPS 治疗的患者。使用单因素和多因素逻辑分析确定与 3 个月内发生 OHE、1 年死亡率和早期 TIPS 后肝功能障碍相关的独立危险因素。建立并内部验证基于独立危险因素的人工神经网络(ANN)模型和预测列线图。

结果

共纳入 207 例患者,其中 33 例(15.9%)在 TIPS 治疗后 3 个月内发生 OHE。白蛋白-胆红素分级(P=0.015)、年龄(≤65 岁,>65 岁)(P<0.001)、性别(P=0.002)和酒精性肝硬化(P=0.013)是与 3 个月 OHE 相关的独立危险因素。门静脉血栓形成(P=0.034)和终末期肝病模型评分(P=0.063)是与 1 年死亡率相关的独立危险因素。血小板-白蛋白-胆红素分级(P=0.041)和肝性脑病史(P=0.018)是与 TIPS 治疗后肝功能障碍相关的独立危险因素。然后建立并验证了三个 ANN 模型和三个列线图,具有较高的准确性。

结论

ANN 和列线图模型有可能准确预测肝硬化急性静脉曲张出血患者接受早期 TIPS 治疗后早期发生 OHE、死亡率和肝功能障碍的风险。

相似文献

1
Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation.单中心回顾性人工智能训练队列研究早期 TIPS 治疗后肝性脑病、死亡率和肝功能障碍的预后预测。
Cardiovasc Intervent Radiol. 2021 Oct;44(10):1597-1608. doi: 10.1007/s00270-021-02907-0. Epub 2021 Jul 8.
2
Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.人工智能在预测肝硬化急性静脉曲张出血行早期经颈静脉肝内门体分流术患者预后中的白蛋白-胆红素和血小板-白蛋白-胆红素模型的性能。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e153-e160. doi: 10.1097/MEG.0000000000001989.
3
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.经颈静脉肝内门体分流术后发作性显性肝性脑病不会增加肝硬化患者的死亡率。
J Hepatol. 2024 Apr;80(4):596-602. doi: 10.1016/j.jhep.2023.11.033. Epub 2023 Dec 13.
4
Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.肝硬化患者经颈静脉肝内门体分流术(TIPS)后门静脉高压性脑病的危险因素。
J Dig Dis. 2021 Jan;22(1):31-40. doi: 10.1111/1751-2980.12957. Epub 2020 Nov 26.
5
Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术所致显性肝性脑病的术前预测。
Eur J Radiol. 2022 Sep;154:110384. doi: 10.1016/j.ejrad.2022.110384. Epub 2022 May 28.
6
Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.经颈静脉肝内门体分流术治疗患者的死亡率和显性肝性脑病预测:一项回顾性队列研究。
Abdom Radiol (NY). 2024 Mar;49(3):908-918. doi: 10.1007/s00261-023-04086-7. Epub 2023 Nov 13.
7
Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后肝硬化患者显性肝性脑病新指标:营养状态评分。
Clin Nutr. 2022 Feb;41(2):560-566. doi: 10.1016/j.clnu.2021.12.036. Epub 2022 Jan 4.
8
Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.早期复发性显性肝性脑病与经颈静脉肝内门体分流术后肝硬化患者生存率降低有关。
J Vasc Interv Radiol. 2019 Feb;30(2):148-153.e2. doi: 10.1016/j.jvir.2018.08.023. Epub 2019 Jan 9.
9
Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.非静脉曲张性自发性门体分流与肝硬化 TIPS 术后结局的关系。
Dig Liver Dis. 2018 Dec;50(12):1315-1323. doi: 10.1016/j.dld.2018.05.022. Epub 2018 Jun 5.
10
Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.经颈静脉肝内门体分流术治疗未选择患者群体的静脉曲张出血。
Scand J Gastroenterol. 2018 Jan;53(1):70-75. doi: 10.1080/00365521.2017.1386795. Epub 2017 Oct 9.

引用本文的文献

1
Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: A comprehensive minireview.肝硬化患者经颈静脉肝内门体分流术后肝性脑病的危险因素:一篇综合性的小型综述
World J Hepatol. 2025 Aug 27;17(8):109678. doi: 10.4254/wjh.v17.i8.109678.
2
Machine learning techniques in hepatic encephalopathy: a scoping review.肝性脑病中的机器学习技术:一项范围综述
BMC Med Inform Decis Mak. 2025 Sep 1;25(1):323. doi: 10.1186/s12911-025-03168-4.
3
Can Artificial Intelligence and Machine Learning Transform Prediction and Treatment of Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Overt Hepatic Encephalopathy?

本文引用的文献

1
Prognostic Performance of Albumin-Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.人工智能辅助下白蛋白-胆红素分级对经动脉化疗栓塞联合索拉非尼治疗的肝细胞癌的预后评估价值
Front Oncol. 2020 Dec 18;10:525461. doi: 10.3389/fonc.2020.525461. eCollection 2020.
2
Combining immune checkpoint inhibitor with lenvatinib prolongs survival than lenvatinib alone in sorafenib-experienced hepatocellular carcinoma patients.联合免疫检查点抑制剂和仑伐替尼治疗索拉非尼经治的肝细胞癌患者比单独使用仑伐替尼能显著延长患者的总生存期。
Eur J Gastroenterol Hepatol. 2022 Feb 1;34(2):213-219. doi: 10.1097/MEG.0000000000001956.
3
人工智能和机器学习能否改变经颈静脉肝内门体分流术(TIPS)显性肝性脑病的预测与治疗?
Gastro Hep Adv. 2024 Sep 30;4(2):100560. doi: 10.1016/j.gastha.2024.09.015. eCollection 2025.
4
Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.经颈静脉肝内门体分流术后肝性脑病:预测评估的现状与前景
Comput Struct Biotechnol J. 2024 Jul 10;24:493-506. doi: 10.1016/j.csbj.2024.07.008. eCollection 2024 Dec.
5
Interventional radiology and the liver vasculature: A personal perspective.介入放射学与肝脏血管系统:个人观点。
Clin Liver Dis (Hoboken). 2024 Jun 25;23(1):e0239. doi: 10.1097/CLD.0000000000000239. eCollection 2024 Jan-Jun.
6
Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy-A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.经颈静脉肝内门体分流术(TIPS)相关性肝性脑病——基于发病率、危险因素及预防的过去十年文献综述
J Clin Med. 2023 Dec 19;13(1):14. doi: 10.3390/jcm13010014.
7
Machine Learning Insights: Predicting Hepatic Encephalopathy After TIPS Placement.机器学习洞察:预测 TIPS 放置后肝性脑病。
Cardiovasc Intervent Radiol. 2023 Dec;46(12):1715-1725. doi: 10.1007/s00270-023-03593-w. Epub 2023 Nov 17.
8
Establishment and validation of a nomogram model for riskprediction of hepatic encephalopathy: a retrospective analysis.建立和验证肝性脑病风险预测的列线图模型:一项回顾性分析。
Sci Rep. 2023 Nov 9;13(1):19544. doi: 10.1038/s41598-023-47012-z.
9
Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review.血浆白蛋白在预后指标中的作用解读:文献综述
J Clin Med. 2023 Sep 22;12(19):6132. doi: 10.3390/jcm12196132.
Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
人工智能在预测肝硬化急性静脉曲张出血行早期经颈静脉肝内门体分流术患者预后中的白蛋白-胆红素和血小板-白蛋白-胆红素模型的性能。
Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e153-e160. doi: 10.1097/MEG.0000000000001989.
4
Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis.肝硬化患者经颈静脉肝内门体分流术(TIPS)后门静脉高压性脑病的危险因素。
J Dig Dis. 2021 Jan;22(1):31-40. doi: 10.1111/1751-2980.12957. Epub 2020 Nov 26.
5
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.早期 TIPS(经颈静脉肝内门体分流术)联合覆膜支架与标准治疗对肝硬化急性静脉曲张出血患者的随机对照试验。
Lancet Gastroenterol Hepatol. 2019 Aug;4(8):587-598. doi: 10.1016/S2468-1253(19)30090-1. Epub 2019 May 29.
6
Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology.肝硬化性肝性脑病:病理学与病理生理学。
Drugs. 2019 Feb;79(Suppl 1):17-21. doi: 10.1007/s40265-018-1017-0.
7
Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.肝细胞癌:基于白蛋白-胆红素分级的列线图评估射频消融治疗结局。
Radiology. 2017 Nov;285(2):670-680. doi: 10.1148/radiol.2017162382. Epub 2017 May 30.
8
Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).经颈静脉肝内门体分流术(TIPS)后肝性脑病的观察性队列研究。
Ann Hepatol. 2017 Jan-Feb;16(1):140-148. doi: 10.5604/16652681.1226932.
9
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma.ALBI 分级为各巴塞罗那临床肝癌分期提供了客观的肝脏储备功能评估。
J Hepatol. 2017 Feb;66(2):338-346. doi: 10.1016/j.jhep.2016.09.008. Epub 2016 Sep 24.
10
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.门静脉高压领域共识的拓展:巴韦诺VI共识研讨会报告:门静脉高压风险分层与个体化治疗
J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.